Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials.
Omar Abdel-RahmanS GhoshJ WalkerPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
Antibiotic use before (but not following) the start of 5FU-based chemotherapy is associated with worse progression-free and overall survival among patients with metastatic colorectal cancer.
Keyphrases
- metastatic colorectal cancer
- data analysis
- clinical trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- locally advanced
- prognostic factors
- case report
- type diabetes
- squamous cell carcinoma
- randomized controlled trial
- radiation therapy
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- skeletal muscle
- rectal cancer
- free survival